Azolato-Bridged Dinuclear Platinum(II) Complexes Exhibit Androgen Receptor-Mediated Anti-Prostate Cancer Activity
Inorganic Chemistry · 2024
DOI: 10.1021/acs.inorgchem.4c01093 ↗Kurz gefasst
Fachartikel in der Zeitschrift Inorganic Chemistry, 2024. Verfasst von Tasuku Arai und 11 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Biochemistry, Department of Bioscience and Engineering, College of Systems Engineering and Science, Shibaura Institute of Technology, S…. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Receptors, Androgen, Antineoplastic Agents, Cell Proliferation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Prostate cancer is an androgen-dependent malignancy that presents a marked treatment challenge, particularly after progression to the castration-resistant stage. Traditional treatments such as androgen deprivation therapy often lead to resistance, necessitating novel therapeutic approaches. Previous studies have indicated that some of the azolato-bridged dinuclear platinum(II) complexes (general formula: [{cis-Pt(NH3)2}2(μ-OH)(μ-azolato)]X2, where azolato = pyrazolato, 1,2,3-triazolato, or tetrazolato and X = nitrate or perchlorate) inhibit androgen receptor (AR) signaling. Therefore, here we investigated the potential of 14 such complexes as agents for the treatment of prostate cancer by examining their antiproliferative activity in the human prostate adenocarcinoma cell line LNCaP. Several of the complexes, particularly 5-H-Y ([{cis-Pt(NH3)2}2(μ-OH)(μ-tetrazolato-N2,N3)](ClO4)2), effectively inhibited LNCaP cell growth, even at low concentrations, by direct modulation of AR signaling, and by binding to DNA and inducing apoptosis, which is a common mechanism of action of Pt-based drugs such as cisplatin (cis-diamminedichloridoplatinum(II)). Comparative analysis with cisplatin revealed superior inhibitory effects of these complexes. Further investigation revealed that 5-H-Y suppressed mRNA expression of genes downstream from AR and induced apoptosis, particularly in cells overexpressing AR, highlighting its potential as an AR antagonist. Thus, we provide here insights into the mechanisms underlying the antiproliferative effects of azolato-bridged complexes in prostate cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Laboratory of Biochemistry, Department of Bioscience and Engineering, College of Systems Engineering and Science, Shibaura Institute of Technology, Saitama, Saitama 337-8570, Japan.
- Medicinal Chemistry and Organic Synthesis, Department of Systems Engineering and Science, Graduate School of Engineering and Science, Shibaura Institute of Technology, Saitama, Saitama 337-8570, Japan.
- Department of Urology, Jichi Medical University Saitama Medical Center, Saitama, Saitama 330-8503, Japan.
- Division of Hematology and Oncology, Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, Ohio 45267, United States.
- Faculty of Pharmaceutical Sciences, Suzuka University of Medical Science, Suzuka, Mie 513-8670, Japan.
- Laboratory of Organic Synthesis and Medicinal Chemistry, Department of Bioscience and Engineering, College of Systems Engineering and Science, Shibaura Institute of Technology, Saitama, Saitama 337-8570, Japan.
ORCID-Profile: Seiji Komeda, Yoshihisa Hirota
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Arai, T., Oshima, M., Uemura, M., Matsunaga, T., Ashizawa, T., Suhara, Y., Morii, M., Yoneyama, H., Usami, Y., Harusawa, S., Komeda, S., & Hirota, Y. (2024). Azolato-Bridged Dinuclear Platinum(II) Complexes Exhibit Androgen Receptor-Mediated Anti-Prostate Cancer Activity. Inorganic Chemistry. https://doi.org/10.1021/acs.inorgchem.4c01093
Vancouver
Arai T, Oshima M, Uemura M, Matsunaga T, Ashizawa T, Suhara Y, et al. Azolato-Bridged Dinuclear Platinum(II) Complexes Exhibit Androgen Receptor-Mediated Anti-Prostate Cancer Activity. Inorganic Chemistry. 2024. doi:10.1021/acs.inorgchem.4c01093
BibTeX
@article{Arai2024,
author = {Arai, Tasuku and Oshima, Masashi and Uemura, Masako and Matsunaga, Takeshi and Ashizawa, Taiki and Suhara, Yoshitomo and Morii, Magotoshi and Yoneyama, Hiroki and Usami, Yoshihide and Harusawa, Shinya and Komeda, Seiji and Hirota, Yoshihisa},
title = {Azolato-Bridged Dinuclear Platinum(II) Complexes Exhibit Androgen Receptor-Mediated Anti-Prostate Cancer Activity},
journal = {Inorganic Chemistry},
year = {2024},
doi = {10.1021/acs.inorgchem.4c01093}
}
EUVIMED